Literature DB >> 8423356

A new portable device for automatic controlled-gradient cryopreservation of blood mononuclear cells.

L Hviid1, G Albeck, B Hansen, T G Theander, A Talbot.   

Abstract

Protection of the functional integrity of mononuclear cells stored in liquid N2 requires careful control of the freezing procedure. Consequently, optimal quality of cryopreserved cells is usually assured by freezing according to a specified time-temperature gradient generated by computer-controlled freezing devices. While such equipment offers large capacity and secures maximum survival and functional integrity of the lymphocytes upon thawing, it is quite costly and strictly stationary. We have previously developed and tested an alternative, manual device for controlled-gradient lymphocyte freezing, which has proved suitable for field conditions. We report here the development and testing of a similar micro-controller regulated device, allowing unattended and automatic controlled-gradient cell freezing. The equipment exploits the temperature gradient present between the liquid N2 surface and the neck in an ordinary liquid N2 refrigerator. The lymphocyte samples are placed in a small elevator, which is moved through the N2 gas phase by a stepper motor. Time and temperature are measured at regular intervals, and the position of the samples adjusted to ensure that the actual measurements closely match encoded ideal values. Results of assays of the functional integrity and phenotypic composition of human mononuclear cells frozen by the new system were comparable to those obtained when using cells frozen by a commercially available, stationary cell-freezing equipment, or fresh autologous cell samples tested in parallel. Furthermore, there was a good correlation between functional and phenotypic data obtained using frozen and autologous fresh samples of mononuclear cells. The equipment described is low weight and has low N2 consumption, and is thus suitable for the collection and cryopreservation of lymphocytes under field conditions. Furthermore, the technique provides an inexpensive alternative for researchers with a limited requirement for the simultaneous freezing of large quantities of cells.

Entities:  

Mesh:

Year:  1993        PMID: 8423356     DOI: 10.1016/0022-1759(93)90079-m

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  16 in total

1.  West African donors have high percentages of activated cytokine producing T cells that are prone to apoptosis.

Authors:  K Kemp; B D Akanmori; L Hviid
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

2.  Cytokine production and apoptosis among T cells from patients under treatment for Plasmodium falciparum malaria.

Authors:  K Kemp; B D Akanmori; V Adabayeri; B Q Goka; J A L Kurtzhals; C Behr; L Hviid
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

3.  Increased levels of soluble CD30 in plasma of patients with Plasmodium falciparum malaria.

Authors:  Kåre Kemp; Jørgen A L Kurtzhals; Bartholomew D Akanmori; Victoria Adabayeri; Bamenla Q Goka; Charlotte Behr; Lars Hviid
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

4.  Presence of IgE cells in human placenta is independent of malaria infection or chorioamnionitis.

Authors:  E Rindsjö; I Hulthén Varli; M F Ofori; M Lundquist; U Holmlund; N Papadogiannakis; A Scheynius
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

5.  Kinetics of B cell responses to Plasmodium falciparum erythrocyte membrane protein 1 in Ghanaian women naturally exposed to malaria parasites.

Authors:  Paulina Ampomah; Liz Stevenson; Michael F Ofori; Lea Barfod; Lars Hviid
Journal:  J Immunol       Date:  2014-04-23       Impact factor: 5.422

6.  B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites.

Authors:  Paulina Ampomah; Liz Stevenson; Michael F Ofori; Lea Barfod; Lars Hviid
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

7.  Analysis of human antiviral cytotoxic T-lymphocyte responses for vaccine trials using cryopreserved mononuclear leukocytes: demonstration of feasibility with influenza virus-specific responses.

Authors:  N el-Daher; J E Nichols; N J Roberts
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

8.  Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis.

Authors:  K Kemp; M Kemp; A Kharazmi; A Ismail; J A Kurtzhals; L Hviid; T G Theander
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

9.  Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization.

Authors:  Adriana Weinberg; Lin-Ye Song; Cynthia Wilkening; Anne Sevin; Bruce Blais; Raul Louzao; Dana Stein; Patricia Defechereux; Deborah Durand; Eric Riedel; Nancy Raftery; Renee Jesser; Betty Brown; M Fran Keller; Ruth Dickover; Elizabeth McFarland; Terence Fenton
Journal:  Clin Vaccine Immunol       Date:  2009-06-10

10.  Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA.

Authors:  Lea Barfod; Nadia L Bernasconi; Madeleine Dahlbäck; David Jarrossay; Pernille Haste Andersen; Ali Salanti; Michael F Ofori; Louise Turner; Mafalda Resende; Morten A Nielsen; Thor G Theander; Federica Sallusto; Antonio Lanzavecchia; Lars Hviid
Journal:  Mol Microbiol       Date:  2006-12-14       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.